Home
Our Business
SPI’s Strengths
About Us
Notifications

Bioresource Materials矢印

Bio Research Instruments and Reagents矢印

Drug discovery partnering support矢印

EN
Corporate Profile / Organizational Chart / History
01

Corporate Profile

Overview

Company name

Summit Pharmaceuticals International Corporation

Established

November 21, 1949

Capital

480 million yen (wholly-owned subsidiary of Sumitomo Corporation)

Officers

Katsuya Okuyama, President & CEO Masahito Uno, Director Yasunori Ishibashi, Director Kenji Okuda, Auditor Kosuke Tomitaka, Auditor

Number of
employees

163 (as of February 2024)

Main bank

Sumitomo Mitsui Banking Corporation

Sales

40.1 billion yen (fiscal year ended March 2023)

Businesses

  1. Import, export, and marketing of drugs, quasi-drugs, medical devices, and food additives, as well as materials, bulks, and final products thereof
  2. Import and marketing of microbial, plant and animal cells and tissues and analytical devices as drug discovery support tools, as well as brokerage and mediation of related biological services
  3. Consulting and mediation services concerning pharmaceutical development and new drug licensing

Locations

Head Office

Sumitomo Corporation Takebashi BLD. 12F 1-2-2, Hitotsubashi, Chiyoda-ku, Tokyo 100-0003 TEL : +81-(0)3-5220-1500, FAX : +81-(0)3-5220-1501

Osaka Office

Sumitomo Main Bldg. 7F 4-5-33 Kitahama, Chuo-ku, Osaka City, Osaka 541-0041 TEL : +81-(0)6-6222-3971, FAX : +81-(0)6-6222-6770

Yokohama Support Center

135 Yokohama Bio Industry Center 1-6 Suehiro-cho, Tsurumi-ku, Yokohama City, Kanagawa 230-0045 TEL : +81-(0)45-508-2171, FAX : +81-(0)45-508-2710

API Laboratory

R&D D437 Kanagawa Science Park 3-2-1 Sakado, Takatsu-ku, Kawasaki City, Kanagawa 213-0012 TEL : +81-(0)44-829-1170, FAX : +81-(0)44-844-0371

02

Organization Chart

Organization Chart
03

History

Summit Pharmaceuticals International Corporation

  • 2021
    Expanded the API Laboratory
  • 2021
    Acquired 100% shares of Summit Pharmaceuticals China
  • 2020
    Acquired 100% shares of Summit Pharmaceuticals Europe
  • 2011
    Changed the name of the Yokohama Laboratory to the Yokohama Support Center
  • 2009
    Established the API Laboratory in Takatsu-ku, Kawasaki City
  • 2006
    Summit Medi-Chem merged with Summit Pharmaceuticals International Corporation and inherited its name

Summit Medi-Chem (former name)

  • 2003
    Became a wholly owned business investment company of SC
  • 2003
    Changed the company name to Summit Medi-Chem
  • 1993
    SC invested in Goei Shoji
  • 1949
    Goei Shoji was established Started selling industrial chemicals and medical products

Summit Pharmaceuticals International Corporation (former name)

  • 2006
    Took over business rights concerning marketing and development of physicochemical devices from SC Bioscience Corporation Established the Yokohama Laboratory in Tsurumi-ku, Yokohama City
  • 1995
    Took over the business rights and assets from the New Drugs and Bioscience Department of SC and changed the company name to Summit Pharmaceuticals International Corporation
  • 1985
    Sumisho Pharma Corporation was established as a wholly-owned business investment company of Sumitomo Corporation (SC) Started supporting the New Drugs and Bioscience Department of SC, engaged in drug discovery research support, pharmaceuticals and diagnostics licensing, and other supportive activities